Pulmonx Corp. LUNG 深 滬
等待開盤 01-29 09:30:00 美东时间
1.76
+0.010
+0.57%
華盛通- 最 高1.795
- 今 開1.75
- 成交量 24.81万股
- 最 低 1.73
- 昨 收 1.75
- 總市值 7171.40万
- 52周最高 9.37
- 市盈率 靜 --
- 換手率 0.61%
- 52周最低 1.31
- 委 比 -12.40%
- 總股本 4074.66万
- 歷史最高 69.478
- 量 比 1.10
- 振 幅 3.71%
- 歷史最低 1.31
- 每 手 1
- 風險率 2.14%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Pulmonx Corporation granted equity awards totaling 1,625,000 shares to two new hires in Q4 2025, including Chief Financial Officer and Chief Operating Officer Derrick Sung. 1,225,000 RSUs were awarded, with 1,200,000 allocated to Sung. RSUs vest over four years, with 25% vesting at one year and the rest in quarterly installments. Additionally, Sung received up to 400,000 PSUs, subject to time-based vesting over three years and a performance condi...
2025-12-03 21:05
美股大行评级 | 思科、On Holding、派拓网络等获多家机构上调目标价；Circle 遭富国、德银等多家机构下调目标价
今日重点评级关注：HC Wainwright & Co.：维持PDS Biotechnology"买入"评级，目标价从13美元升至15美元；HC Wainwright & Co.：维持PepGen Inc."买入"评级，目标价从18美元升至20美元
2025-11-14 10:43
D. Boral Capital Maintains Buy on Pulmonx, Maintains $14 Price Target
D. Boral Capital analyst Jason Kolbert maintains Pulmonx (NASDAQ:LUNG) with a Buy and maintains $14 price target.
2025-11-13 21:59
Earnings Scheduled For November 12, 2025
Companies Reporting Before The Bell • Hudbay Minerals (NYSE:HBM) is projected t...
2025-11-12 19:11
Pulmonx reports Q3 Preliminary results
Pulmonx press release (NASDAQ:LUNG): Q3 revenue expected to be approximately $21.5 million More on Pulmonx Pulmonx slumps as Piper Sandler downgrades despite Q2 beat Seeking Alpha’s Quant Rating on ...
2025-10-29 17:31
美股大行评级 | 上调！苹果、亚马逊、Amkor Tech、Cadence、Confluent、卡特、通用动力等获多家上调目标价
今日重点评级关注：HC Wainwright & Co.：维持PepGen"买入"评级，目标价从12美元升至18美元；Piper Sandler：维持Prothena Corp"超配"评级，目标价从15美元升至36美元
2025-10-29 09:25
Pulmonx Announces Management Transition and Preliminary Third Quarter 2025 Revenue; Reschedules Third Quarter 2025 Earnings Call to November 12, 2025
Pulmonx Corporation announced the reappointment of Glen French as President and CEO, effective immediately, and the appointment of Derrick Sung as COO and CFO, effective November 3, 2025. Steve Williamson and Mehul Joshi have resigned from their roles to pursue other opportunities. Preliminary, unaudited third-quarter 2025 revenue is expected to be approximately $21.5 million. The company has rescheduled the release of its third-quarter financial...
2025-10-27 20:05
D. Boral Capital Maintains Buy on Pulmonx, Maintains $16 Price Target
D. Boral Capital analyst Jason Kolbert maintains Pulmonx (NASDAQ:LUNG) with a Buy and maintains $16 price target.
2025-09-08 19:17
Jaeger And Pulmonx Announce Strategic Partnership To Integrate Data Qualification Capabilities Into SentrySuite
Jaeger™ Medical, a global leader in respiratory diagnostic products, is pleased to announce a strategic partnership with Pulmonx Corporation, Redwood City, California, USA, to integrate advanced data
2025-08-27 21:13
